{
    "nctId": "NCT00876070",
    "briefTitle": "Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer",
    "officialTitle": "Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 198,
    "primaryOutcomeMeasure": "Describe patient demographics, disease and treatment characteristics.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients that have received Abraxane chemotherapy greater than three months from the time of chart review.\n* Patients that have received taxane chemotherapy greater than three months from the time of chart review.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}